[Antibiotics and antimycotics in oncology]

Area of Science:

• Oncology
• Infectious Diseases
• Pharmacology

Context:

• Febrile neutropenia is a common and serious complication in cancer patients undergoing chemotherapy.
• Bone marrow transplantation requires intensive immunosuppression, increasing infection risk.
• Managing infections in immunocompromised patients is critical for treatment success.

Purpose:

• To review current and emerging antimicrobial and antimycotic agents for oncologic indications.
• To outline strategies for infection prophylaxis and treatment in neutropenic patients.
• To discuss the role of these agents in bone marrow transplantation protocols.

Summary:

• The review details therapeutic and prophylactic uses of novel antimicrobial and antimycotic drugs.
• It addresses empirical and targeted treatments for febrile neutropenia.
• Focus is placed on infection prevention during neutropenic episodes and selective decontamination in transplantation.

Impact:

• Provides an updated overview of antimicrobial and antimycotic therapies for immunocompromised cancer patients.
• Informs clinical practice regarding infection management in neutropenia and transplantation.
• Highlights the importance of new agents in improving outcomes for oncology patients.